Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of ...
Hailed as the first Chinese company to launch a homegrown antibody drug conjugate (ADC), RemeGen has recently been battling a ...
The Motley Fool on MSN23m
This Could Be the Catalyst That Sends Summit Therapeutics' Stock Higher This YearSummit Therapeutics (NASDAQ: SMMT) has been one of the hottest stocks to own over the past 12 months, with its valuation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback